Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Explore advanced CRISPR gene editing technologies and their therapeutic applications in this 42-minute webinar presented by GenScript's Roumen Bogoev. Discover how CRISPR has revolutionized gene modification by offering unprecedented ease and flexibility compared to viral-based approaches, and learn about the diverse range of CRISPR enzymes including CAS-9, CAS-12, and CAS-13, each with unique specificities and modalities. Examine the latest developments in Base and Prime editing that enhance CRISPR performance by increasing specificity and efficiency. Gain insights into GenScript's comprehensive portfolio of high-quality CRISPR services and products designed to support different stages of therapeutics development, from initial discovery through lead generation and optimization to pre-clinical and clinical development phases. Understand how these advanced solutions can streamline your gene editing workflows and accelerate therapeutic development timelines. The webinar is presented by Roumen Bogoev, who brings over 14 years of marketing experience and 15 years of research and development expertise as head of segment marketing for GenScript, where he develops go-to-market strategies for critical applications including antibody therapeutics, gene therapy, cell therapy, vaccines, and in vitro diagnostics. Participants can earn PACE credits by registering with Labroots and completing the viewing requirements.
